vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Commercial Vehicle Group, Inc. (CVGI). Click either name above to swap in a different company.
Commercial Vehicle Group, Inc. is the larger business by last-quarter revenue ($154.8M vs $83.5M, roughly 1.9× BillionToOne, Inc.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -5.2%). Commercial Vehicle Group, Inc. produced more free cash flow last quarter ($8.7M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
BLLN vs CVGI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $154.8M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | 9.7% |
| Operating Margin | 11.5% | -1.2% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | -5.2% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $154.8M | ||
| Q3 25 | $83.5M | $152.5M | ||
| Q2 25 | — | $172.0M | ||
| Q1 25 | — | $169.8M | ||
| Q4 24 | — | $163.3M | ||
| Q3 24 | $38.4M | $171.8M | ||
| Q2 24 | — | $193.7M | ||
| Q1 24 | — | $194.6M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $-7.1M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.9M | $9.5M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $2.9M |
| Q4 25 | — | 9.7% | ||
| Q3 25 | 69.9% | 10.5% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 10.5% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 52.6% | 9.6% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | -1.2% | ||
| Q3 25 | 11.5% | -0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | -3.2% | ||
| Q3 24 | -32.9% | -0.6% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | -4.6% | ||
| Q2 25 | — | -2.8% | ||
| Q1 25 | — | -2.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | 5.5% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | — | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.47 | — | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | — | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | — |
| Total DebtLower is stronger | $55.0M | $104.9M |
| Stockholders' EquityBook value | $-239.5M | $133.4M |
| Total Assets | $327.5M | $391.7M |
| Debt / EquityLower = less leverage | — | 0.79× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $104.9M | ||
| Q3 25 | $55.0M | $108.2M | ||
| Q2 25 | — | $118.2M | ||
| Q1 25 | — | $117.4M | ||
| Q4 24 | — | $135.5M | ||
| Q3 24 | — | $128.8M | ||
| Q2 24 | — | $142.0M | ||
| Q1 24 | — | $155.7M |
| Q4 25 | — | $133.4M | ||
| Q3 25 | $-239.5M | $136.5M | ||
| Q2 25 | — | $142.6M | ||
| Q1 25 | — | $136.7M | ||
| Q4 24 | — | $135.6M | ||
| Q3 24 | $-242.9M | $179.3M | ||
| Q2 24 | — | $169.6M | ||
| Q1 24 | — | $175.5M |
| Q4 25 | — | $391.7M | ||
| Q3 25 | $327.5M | $400.3M | ||
| Q2 25 | — | $429.8M | ||
| Q1 25 | — | $419.8M | ||
| Q4 24 | — | $424.6M | ||
| Q3 24 | — | $495.3M | ||
| Q2 24 | — | $503.2M | ||
| Q1 24 | — | $509.2M |
| Q4 25 | — | 0.79× | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 1.00× | ||
| Q3 24 | — | 0.72× | ||
| Q2 24 | — | 0.84× | ||
| Q1 24 | — | 0.89× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $12.3M |
| Free Cash FlowOCF − Capex | $6.5M | $8.7M |
| FCF MarginFCF / Revenue | 7.7% | 5.6% |
| Capex IntensityCapex / Revenue | 8.8% | 2.3% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $12.3M | ||
| Q3 25 | $13.8M | $-1.7M | ||
| Q2 25 | — | $18.9M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $-26.6M | ||
| Q3 24 | — | $-17.1M | ||
| Q2 24 | — | $12.6M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | — | $8.7M | ||
| Q3 25 | $6.5M | $-3.5M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $-30.6M | ||
| Q3 24 | — | $-20.3M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $-7.4M |
| Q4 25 | — | 5.6% | ||
| Q3 25 | 7.7% | -2.3% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | -18.7% | ||
| Q3 24 | — | -11.8% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | -3.8% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 8.8% | 1.2% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.79× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
